

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.81369377 |
| 2 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 5.01839264 |
| 3 | regulation of memory T cell differentiation (GO:0043380) | 4.92773790 |
| 4 | behavioral response to nicotine (GO:0035095) | 4.62345904 |
| 5 | platelet dense granule organization (GO:0060155) | 4.61969757 |
| 6 | cytidine deamination (GO:0009972) | 4.50221687 |
| 7 | cytidine metabolic process (GO:0046087) | 4.50221687 |
| 8 | cytidine catabolic process (GO:0006216) | 4.50221687 |
| 9 | negative regulation of thymocyte apoptotic process (GO:0070244) | 4.37076598 |
| 10 | positive regulation of defense response to virus by host (GO:0002230) | 4.36073511 |
| 11 | positive regulation of interleukin-17 production (GO:0032740) | 4.28192562 |
| 12 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.84415164 |
| 13 | tachykinin receptor signaling pathway (GO:0007217) | 3.80142202 |
| 14 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 3.79154401 |
| 15 | response to pheromone (GO:0019236) | 3.74389570 |
| 16 | regulation of regulatory T cell differentiation (GO:0045589) | 3.71041515 |
| 17 | L-fucose catabolic process (GO:0042355) | 3.57425387 |
| 18 | fucose catabolic process (GO:0019317) | 3.57425387 |
| 19 | L-fucose metabolic process (GO:0042354) | 3.57425387 |
| 20 | regulation of cilium movement (GO:0003352) | 3.52950440 |
| 21 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.43478340 |
| 22 | negative regulation of B cell apoptotic process (GO:0002903) | 3.31726899 |
| 23 | inositol phosphate dephosphorylation (GO:0046855) | 3.29925573 |
| 24 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 3.29925573 |
| 25 | inositol phosphate catabolic process (GO:0071545) | 3.23911107 |
| 26 | regulation of thymocyte apoptotic process (GO:0070243) | 3.21327328 |
| 27 | regulation of tyrosine phosphorylation of Stat5 protein (GO:0042522) | 3.12424926 |
| 28 | piRNA metabolic process (GO:0034587) | 3.10244135 |
| 29 | respiratory chain complex IV assembly (GO:0008535) | 3.09131562 |
| 30 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.06216259 |
| 31 | aggressive behavior (GO:0002118) | 3.02922050 |
| 32 | regulation of action potential (GO:0098900) | 3.01943359 |
| 33 | adaptation of signaling pathway (GO:0023058) | 3.00164487 |
| 34 | negative regulation by host of viral transcription (GO:0043922) | 2.99119691 |
| 35 | cytochrome complex assembly (GO:0017004) | 2.97263074 |
| 36 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.95672963 |
| 37 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.95638320 |
| 38 | regulation of B cell apoptotic process (GO:0002902) | 2.91853490 |
| 39 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.90555797 |
| 40 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.89458161 |
| 41 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.86993752 |
| 42 | auditory receptor cell stereocilium organization (GO:0060088) | 2.86669970 |
| 43 | rRNA catabolic process (GO:0016075) | 2.82917002 |
| 44 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.82619448 |
| 45 | detection of light stimulus involved in visual perception (GO:0050908) | 2.82619448 |
| 46 | signal peptide processing (GO:0006465) | 2.80679313 |
| 47 | regulation of defense response to virus by host (GO:0050691) | 2.77270328 |
| 48 | dopamine transport (GO:0015872) | 2.75460971 |
| 49 | reflex (GO:0060004) | 2.73513696 |
| 50 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.71497431 |
| 51 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.70339747 |
| 52 | polyol catabolic process (GO:0046174) | 2.70032521 |
| 53 | S-adenosylmethionine metabolic process (GO:0046500) | 2.69107686 |
| 54 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.68126366 |
| 55 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.67657164 |
| 56 | protein complex biogenesis (GO:0070271) | 2.66294983 |
| 57 | regulation of chronic inflammatory response (GO:0002676) | 2.60927809 |
| 58 | resolution of meiotic recombination intermediates (GO:0000712) | 2.58730281 |
| 59 | axoneme assembly (GO:0035082) | 2.56765709 |
| 60 | mast cell activation involved in immune response (GO:0002279) | 2.56304075 |
| 61 | mast cell degranulation (GO:0043303) | 2.56304075 |
| 62 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.55916893 |
| 63 | regulation of germinal center formation (GO:0002634) | 2.55807637 |
| 64 | regulation of activation of Janus kinase activity (GO:0010533) | 2.55405995 |
| 65 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.54022278 |
| 66 | protein-cofactor linkage (GO:0018065) | 2.53493459 |
| 67 | activated T cell proliferation (GO:0050798) | 2.52785290 |
| 68 | reciprocal meiotic recombination (GO:0007131) | 2.52213710 |
| 69 | reciprocal DNA recombination (GO:0035825) | 2.52213710 |
| 70 | positive regulation of fatty acid transport (GO:2000193) | 2.51450332 |
| 71 | regulation of hexokinase activity (GO:1903299) | 2.48783095 |
| 72 | regulation of glucokinase activity (GO:0033131) | 2.48783095 |
| 73 | regulation of microtubule-based movement (GO:0060632) | 2.47224229 |
| 74 | cellular response to ethanol (GO:0071361) | 2.45874449 |
| 75 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.45545602 |
| 76 | nonmotile primary cilium assembly (GO:0035058) | 2.45483782 |
| 77 | multicellular organism reproduction (GO:0032504) | 2.43997716 |
| 78 | cellular ketone body metabolic process (GO:0046950) | 2.43507964 |
| 79 | GPI anchor metabolic process (GO:0006505) | 2.42628050 |
| 80 | recombinational repair (GO:0000725) | 2.42199756 |
| 81 | positive regulation of cell fate commitment (GO:0010455) | 2.42037908 |
| 82 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.41894678 |
| 83 | double-strand break repair via homologous recombination (GO:0000724) | 2.40282565 |
| 84 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.40193651 |
| 85 | regulation of interleukin-17 production (GO:0032660) | 2.38741290 |
| 86 | negative regulation of appetite (GO:0032099) | 2.38718357 |
| 87 | negative regulation of response to food (GO:0032096) | 2.38718357 |
| 88 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.37649006 |
| 89 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.37649006 |
| 90 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.35468688 |
| 91 | T cell differentiation (GO:0030217) | 2.35379901 |
| 92 | regulation of immunoglobulin secretion (GO:0051023) | 2.35214496 |
| 93 | cytokine biosynthetic process (GO:0042089) | 2.34602987 |
| 94 | DNA double-strand break processing (GO:0000729) | 2.34053527 |
| 95 | neuronal action potential propagation (GO:0019227) | 2.33399472 |
| 96 | negative regulation of T cell apoptotic process (GO:0070233) | 2.33051959 |
| 97 | positive regulation of protein homooligomerization (GO:0032464) | 2.32775061 |
| 98 | protein K6-linked ubiquitination (GO:0085020) | 2.32054197 |
| 99 | gamma-aminobutyric acid transport (GO:0015812) | 2.31120363 |
| 100 | DNA methylation involved in gamete generation (GO:0043046) | 2.30227261 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_22108803_ChIP-Seq_LS180_Human | 3.39577570 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.05170703 |
| 3 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.97370605 |
| 4 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.59978006 |
| 5 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.48602976 |
| 6 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.47920589 |
| 7 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.47392403 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.31397658 |
| 9 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.29983792 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.19539357 |
| 11 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.17848053 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.16414136 |
| 13 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.02613811 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.00472707 |
| 15 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.98861714 |
| 16 | EWS_26573619_Chip-Seq_HEK293_Human | 1.97766087 |
| 17 | P300_19829295_ChIP-Seq_ESCs_Human | 1.93055477 |
| 18 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.90712040 |
| 19 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.89865779 |
| 20 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.82765264 |
| 21 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.77459080 |
| 22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.76406372 |
| 23 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.66589007 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.66128329 |
| 25 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.63750658 |
| 26 | FUS_26573619_Chip-Seq_HEK293_Human | 1.63083222 |
| 27 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.61831949 |
| 28 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.61444597 |
| 29 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.60096362 |
| 30 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.60041330 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.59936260 |
| 32 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.59796470 |
| 33 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.59689846 |
| 34 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.59689846 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.56022746 |
| 36 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.53407206 |
| 37 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.53080446 |
| 38 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.51739204 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51015128 |
| 40 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.50422178 |
| 41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.49105744 |
| 42 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.48296994 |
| 43 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.48296994 |
| 44 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.45689790 |
| 45 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.43042874 |
| 46 | GATA3_26560356_Chip-Seq_TH2_Human | 1.42048721 |
| 47 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.40826591 |
| 48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.39679721 |
| 49 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.37946804 |
| 50 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.37880147 |
| 51 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.35617210 |
| 52 | TCF4_23295773_ChIP-Seq_U87_Human | 1.33643417 |
| 53 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.33544199 |
| 54 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.32775527 |
| 55 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.30719349 |
| 56 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.30044613 |
| 57 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.29683156 |
| 58 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.29661690 |
| 59 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.29327318 |
| 60 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.29327318 |
| 61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.28879158 |
| 62 | STAT3_23295773_ChIP-Seq_U87_Human | 1.28804243 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28718028 |
| 64 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.27213043 |
| 65 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.26036266 |
| 66 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.25420223 |
| 67 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.24761658 |
| 68 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.24311952 |
| 69 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23235274 |
| 70 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.22736383 |
| 71 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.21504694 |
| 72 | AR_25329375_ChIP-Seq_VCAP_Human | 1.20877745 |
| 73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20594790 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.20593004 |
| 75 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.19497778 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.19312351 |
| 77 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18501652 |
| 78 | AR_20517297_ChIP-Seq_VCAP_Human | 1.18129798 |
| 79 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.17564039 |
| 80 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.17458055 |
| 81 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16133031 |
| 82 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.15663634 |
| 83 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.15573136 |
| 84 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.15423747 |
| 85 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13766800 |
| 86 | NCOR_22424771_ChIP-Seq_293T_Human | 1.13051968 |
| 87 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.12994589 |
| 88 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12420169 |
| 89 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.11457527 |
| 90 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.11446801 |
| 91 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.10890589 |
| 92 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.09173830 |
| 93 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.08969178 |
| 94 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.08805269 |
| 95 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08477099 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.08091434 |
| 97 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.07319739 |
| 98 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.07034514 |
| 99 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06610118 |
| 100 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06439270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002876_abnormal_thyroid_physiology | 3.48859570 |
| 2 | MP0005671_abnormal_response_to | 3.12937123 |
| 3 | MP0000372_irregular_coat_pigmentation | 2.92680905 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.78469403 |
| 5 | MP0002166_altered_tumor_susceptibility | 2.41035875 |
| 6 | MP0008872_abnormal_physiological_respon | 2.40083013 |
| 7 | MP0001968_abnormal_touch/_nociception | 2.34263399 |
| 8 | MP0005645_abnormal_hypothalamus_physiol | 2.15975802 |
| 9 | MP0009785_altered_susceptibility_to | 2.05024039 |
| 10 | MP0002102_abnormal_ear_morphology | 2.03631645 |
| 11 | MP0002132_abnormal_respiratory_system | 2.02639133 |
| 12 | MP0002736_abnormal_nociception_after | 1.97212964 |
| 13 | MP0003195_calcinosis | 1.92737330 |
| 14 | MP0003646_muscle_fatigue | 1.91419039 |
| 15 | MP0001986_abnormal_taste_sensitivity | 1.90659608 |
| 16 | MP0005551_abnormal_eye_electrophysiolog | 1.89961520 |
| 17 | MP0008877_abnormal_DNA_methylation | 1.87955918 |
| 18 | MP0004147_increased_porphyrin_level | 1.86652600 |
| 19 | MP0001984_abnormal_olfaction | 1.83594685 |
| 20 | MP0005387_immune_system_phenotype | 1.79409615 |
| 21 | MP0001790_abnormal_immune_system | 1.79409615 |
| 22 | MP0003011_delayed_dark_adaptation | 1.78701226 |
| 23 | MP0001501_abnormal_sleep_pattern | 1.73168863 |
| 24 | MP0002006_tumorigenesis | 1.70228827 |
| 25 | MP0000685_abnormal_immune_system | 1.69866637 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.69462719 |
| 27 | MP0000013_abnormal_adipose_tissue | 1.68495875 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.68214215 |
| 29 | MP0002933_joint_inflammation | 1.66455211 |
| 30 | MP0001800_abnormal_humoral_immune | 1.64317687 |
| 31 | MP0005253_abnormal_eye_physiology | 1.61950041 |
| 32 | MP0002277_abnormal_respiratory_mucosa | 1.54605507 |
| 33 | MP0003763_abnormal_thymus_physiology | 1.53402440 |
| 34 | MP0005167_abnormal_blood-brain_barrier | 1.45238192 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.43990502 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.41334973 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.40761047 |
| 38 | MP0006292_abnormal_olfactory_placode | 1.39358350 |
| 39 | MP0005174_abnormal_tail_pigmentation | 1.36693687 |
| 40 | MP0006072_abnormal_retinal_apoptosis | 1.36637354 |
| 41 | MP0009764_decreased_sensitivity_to | 1.35559283 |
| 42 | MP0004043_abnormal_pH_regulation | 1.34399382 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.33589557 |
| 44 | MP0003724_increased_susceptibility_to | 1.33535711 |
| 45 | MP0005000_abnormal_immune_tolerance | 1.32987069 |
| 46 | MP0010386_abnormal_urinary_bladder | 1.32557824 |
| 47 | MP0003787_abnormal_imprinting | 1.32001501 |
| 48 | MP0009745_abnormal_behavioral_response | 1.31351985 |
| 49 | MP0010155_abnormal_intestine_physiology | 1.28558073 |
| 50 | MP0004885_abnormal_endolymph | 1.26320326 |
| 51 | MP0005389_reproductive_system_phenotype | 1.26190895 |
| 52 | MP0008775_abnormal_heart_ventricle | 1.23736834 |
| 53 | MP0000427_abnormal_hair_cycle | 1.21745255 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.17375406 |
| 55 | MP0002723_abnormal_immune_serum | 1.17347715 |
| 56 | MP0002272_abnormal_nervous_system | 1.16417533 |
| 57 | MP0004142_abnormal_muscle_tone | 1.15202560 |
| 58 | MP0005410_abnormal_fertilization | 1.15132408 |
| 59 | MP0002234_abnormal_pharynx_morphology | 1.12801829 |
| 60 | MP0002938_white_spotting | 1.12675434 |
| 61 | MP0002693_abnormal_pancreas_physiology | 1.11687820 |
| 62 | MP0002420_abnormal_adaptive_immunity | 1.11670627 |
| 63 | MP0001529_abnormal_vocalization | 1.11039991 |
| 64 | MP0005084_abnormal_gallbladder_morpholo | 1.10916509 |
| 65 | MP0002095_abnormal_skin_pigmentation | 1.08593391 |
| 66 | MP0001819_abnormal_immune_cell | 1.08358572 |
| 67 | MP0003252_abnormal_bile_duct | 1.06179375 |
| 68 | MP0001919_abnormal_reproductive_system | 1.03662436 |
| 69 | MP0001764_abnormal_homeostasis | 1.03161785 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.01306151 |
| 71 | MP0002160_abnormal_reproductive_system | 0.99993814 |
| 72 | MP0002452_abnormal_antigen_presenting | 0.96787448 |
| 73 | MP0001486_abnormal_startle_reflex | 0.94286497 |
| 74 | MP0010329_abnormal_lipoprotein_level | 0.90963931 |
| 75 | MP0002735_abnormal_chemical_nociception | 0.90514591 |
| 76 | MP0002138_abnormal_hepatobiliary_system | 0.90023078 |
| 77 | MP0009046_muscle_twitch | 0.89933238 |
| 78 | MP0005386_behavior/neurological_phenoty | 0.89263917 |
| 79 | MP0004924_abnormal_behavior | 0.89263917 |
| 80 | MP0002733_abnormal_thermal_nociception | 0.88363051 |
| 81 | MP0002163_abnormal_gland_morphology | 0.88112198 |
| 82 | MP0004084_abnormal_cardiac_muscle | 0.87159507 |
| 83 | MP0009697_abnormal_copulation | 0.86791963 |
| 84 | MP0000230_abnormal_systemic_arterial | 0.86577889 |
| 85 | MP0002572_abnormal_emotion/affect_behav | 0.86498556 |
| 86 | MP0003718_maternal_effect | 0.85404788 |
| 87 | MP0005379_endocrine/exocrine_gland_phen | 0.85084932 |
| 88 | MP0000689_abnormal_spleen_morphology | 0.84931860 |
| 89 | MP0002398_abnormal_bone_marrow | 0.84416276 |
| 90 | MP0004133_heterotaxia | 0.84311292 |
| 91 | MP0005085_abnormal_gallbladder_physiolo | 0.83476189 |
| 92 | MP0002638_abnormal_pupillary_reflex | 0.81962951 |
| 93 | MP0003567_abnormal_fetal_cardiomyocyte | 0.81456116 |
| 94 | MP0005025_abnormal_response_to | 0.80168279 |
| 95 | MP0002405_respiratory_system_inflammati | 0.80031607 |
| 96 | MP0005310_abnormal_salivary_gland | 0.79927839 |
| 97 | MP0001879_abnormal_lymphatic_vessel | 0.79709796 |
| 98 | MP0000015_abnormal_ear_pigmentation | 0.79130895 |
| 99 | MP0005365_abnormal_bile_salt | 0.78732377 |
| 100 | MP0006082_CNS_inflammation | 0.77232076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thyroiditis (HP:0100646) | 5.61123462 |
| 2 | B lymphocytopenia (HP:0010976) | 5.49351635 |
| 3 | Abnormality of B cell number (HP:0010975) | 5.35194989 |
| 4 | Severe combined immunodeficiency (HP:0004430) | 5.22233879 |
| 5 | Panhypogammaglobulinemia (HP:0003139) | 5.00774290 |
| 6 | Hypoproteinemia (HP:0003075) | 4.91764107 |
| 7 | T lymphocytopenia (HP:0005403) | 4.36303827 |
| 8 | Abnormality of T cell number (HP:0011839) | 4.08139422 |
| 9 | Hypoplasia of the thymus (HP:0000778) | 4.01542506 |
| 10 | Combined immunodeficiency (HP:0005387) | 3.99504071 |
| 11 | IgG deficiency (HP:0004315) | 3.91860059 |
| 12 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.42612078 |
| 13 | Congenital stationary night blindness (HP:0007642) | 3.40255405 |
| 14 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.26004740 |
| 15 | Eosinophilia (HP:0001880) | 3.25173619 |
| 16 | Abnormality of eosinophils (HP:0001879) | 3.11927065 |
| 17 | 3-Methylglutaconic aciduria (HP:0003535) | 3.11651446 |
| 18 | Hypoplasia of the pons (HP:0012110) | 3.01083276 |
| 19 | Abnormality of the pons (HP:0007361) | 2.99899004 |
| 20 | Type II lissencephaly (HP:0007260) | 2.90235125 |
| 21 | Abnormality of T cells (HP:0002843) | 2.89683042 |
| 22 | Abolished electroretinogram (ERG) (HP:0000550) | 2.87598508 |
| 23 | Pancreatic cysts (HP:0001737) | 2.82896961 |
| 24 | Attenuation of retinal blood vessels (HP:0007843) | 2.79014242 |
| 25 | Erythroderma (HP:0001019) | 2.78215713 |
| 26 | Molar tooth sign on MRI (HP:0002419) | 2.74918279 |
| 27 | Abnormality of midbrain morphology (HP:0002418) | 2.74918279 |
| 28 | Methylmalonic aciduria (HP:0012120) | 2.70186987 |
| 29 | Stomatitis (HP:0010280) | 2.68838611 |
| 30 | Increased hepatocellular lipid droplets (HP:0006565) | 2.64559111 |
| 31 | Pendular nystagmus (HP:0012043) | 2.61903539 |
| 32 | Hyperventilation (HP:0002883) | 2.59182855 |
| 33 | Decreased central vision (HP:0007663) | 2.56901602 |
| 34 | Abnormality of the renal cortex (HP:0011035) | 2.51504719 |
| 35 | Pancreatic fibrosis (HP:0100732) | 2.51330923 |
| 36 | Increased corneal curvature (HP:0100692) | 2.49720668 |
| 37 | Keratoconus (HP:0000563) | 2.49720668 |
| 38 | Lipid accumulation in hepatocytes (HP:0006561) | 2.47768303 |
| 39 | Gaze-evoked nystagmus (HP:0000640) | 2.38264323 |
| 40 | Medial flaring of the eyebrow (HP:0010747) | 2.37104411 |
| 41 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.35908128 |
| 42 | Granulocytopenia (HP:0001913) | 2.23317616 |
| 43 | Renal cortical cysts (HP:0000803) | 2.15058047 |
| 44 | Large for gestational age (HP:0001520) | 2.14885064 |
| 45 | Recurrent cutaneous fungal infections (HP:0011370) | 2.12415376 |
| 46 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.12415376 |
| 47 | Recurrent fungal infections (HP:0002841) | 2.11033377 |
| 48 | True hermaphroditism (HP:0010459) | 2.09905377 |
| 49 | Mitochondrial inheritance (HP:0001427) | 2.09793525 |
| 50 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.09199757 |
| 51 | Hypothermia (HP:0002045) | 2.07718594 |
| 52 | Abnormality of the renal medulla (HP:0100957) | 2.06749208 |
| 53 | Methylmalonic acidemia (HP:0002912) | 2.05876325 |
| 54 | Progressive macrocephaly (HP:0004481) | 2.04554723 |
| 55 | Recurrent viral infections (HP:0004429) | 2.03054656 |
| 56 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.02358981 |
| 57 | Encephalitis (HP:0002383) | 2.01622299 |
| 58 | Optic neuritis (HP:0100653) | 2.01113073 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.01113073 |
| 60 | Abnormality of T cell physiology (HP:0011840) | 2.00807095 |
| 61 | Nephronophthisis (HP:0000090) | 2.00236079 |
| 62 | Prostate neoplasm (HP:0100787) | 1.97394803 |
| 63 | Stomach cancer (HP:0012126) | 1.97375476 |
| 64 | Agammaglobulinemia (HP:0004432) | 1.94034979 |
| 65 | Fair hair (HP:0002286) | 1.94004513 |
| 66 | Chronic hepatic failure (HP:0100626) | 1.93640154 |
| 67 | Acute necrotizing encephalopathy (HP:0006965) | 1.92954251 |
| 68 | Renal Fanconi syndrome (HP:0001994) | 1.92352043 |
| 69 | Increased CSF lactate (HP:0002490) | 1.90951860 |
| 70 | Leukocytosis (HP:0001974) | 1.90457901 |
| 71 | Bile duct proliferation (HP:0001408) | 1.87631969 |
| 72 | Abnormal biliary tract physiology (HP:0012439) | 1.87631969 |
| 73 | Abnormal albumin level (HP:0012116) | 1.86513502 |
| 74 | Hypoalbuminemia (HP:0003073) | 1.86513502 |
| 75 | Increased intramyocellular lipid droplets (HP:0012240) | 1.85889802 |
| 76 | Meningitis (HP:0001287) | 1.83797379 |
| 77 | Abnormality of alanine metabolism (HP:0010916) | 1.83218672 |
| 78 | Hyperalaninemia (HP:0003348) | 1.83218672 |
| 79 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.83218672 |
| 80 | Constricted visual fields (HP:0001133) | 1.83070252 |
| 81 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.82421097 |
| 82 | Abnormality of the prostate (HP:0008775) | 1.81447888 |
| 83 | Intestinal atresia (HP:0011100) | 1.80725541 |
| 84 | Hypomagnesemia (HP:0002917) | 1.80411990 |
| 85 | Broad-based gait (HP:0002136) | 1.80308580 |
| 86 | Hematochezia (HP:0002573) | 1.79973079 |
| 87 | Acute encephalopathy (HP:0006846) | 1.79691880 |
| 88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.77183887 |
| 89 | Dicarboxylic aciduria (HP:0003215) | 1.77183887 |
| 90 | Metabolic alkalosis (HP:0200114) | 1.75326554 |
| 91 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.74825750 |
| 92 | Hypoplasia of the fovea (HP:0007750) | 1.74825750 |
| 93 | Severe visual impairment (HP:0001141) | 1.73955864 |
| 94 | Autoimmune hemolytic anemia (HP:0001890) | 1.73445272 |
| 95 | Chronic sinusitis (HP:0011109) | 1.73254393 |
| 96 | Gait imbalance (HP:0002141) | 1.70492442 |
| 97 | Exertional dyspnea (HP:0002875) | 1.68917850 |
| 98 | Ketoacidosis (HP:0001993) | 1.68444672 |
| 99 | Ketosis (HP:0001946) | 1.67475088 |
| 100 | Metaphyseal dysplasia (HP:0100255) | 1.67144414 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.38914923 |
| 2 | TXK | 3.00161588 |
| 3 | ADRBK2 | 2.95750111 |
| 4 | NUAK1 | 2.72769183 |
| 5 | MAP4K2 | 2.69906201 |
| 6 | VRK2 | 2.67955837 |
| 7 | EIF2AK3 | 2.52996995 |
| 8 | TAF1 | 2.47289526 |
| 9 | GRK1 | 2.17332127 |
| 10 | WNK3 | 2.07598964 |
| 11 | MST4 | 2.04986868 |
| 12 | TAOK3 | 1.88413417 |
| 13 | FES | 1.82707092 |
| 14 | BMPR1B | 1.74049455 |
| 15 | PINK1 | 1.68433698 |
| 16 | INSRR | 1.67871791 |
| 17 | TIE1 | 1.65671447 |
| 18 | ZAK | 1.60524595 |
| 19 | ACVR1B | 1.60261585 |
| 20 | WNK4 | 1.59294603 |
| 21 | TLK1 | 1.58345592 |
| 22 | MAP3K12 | 1.54776562 |
| 23 | MAPK13 | 1.48803679 |
| 24 | VRK1 | 1.46056463 |
| 25 | KDR | 1.42497067 |
| 26 | RIPK4 | 1.41205944 |
| 27 | NLK | 1.40560005 |
| 28 | CAMKK2 | 1.29536889 |
| 29 | TEC | 1.26345797 |
| 30 | OXSR1 | 1.13250287 |
| 31 | EIF2AK2 | 1.04976964 |
| 32 | ITK | 1.01047054 |
| 33 | BMPR2 | 1.00533797 |
| 34 | GRK5 | 0.98911668 |
| 35 | DYRK2 | 0.95605388 |
| 36 | IKBKE | 0.93722666 |
| 37 | IKBKB | 0.91478617 |
| 38 | PHKG2 | 0.91251523 |
| 39 | PHKG1 | 0.91251523 |
| 40 | NTRK3 | 0.88630792 |
| 41 | BRSK2 | 0.86481649 |
| 42 | TNIK | 0.85676961 |
| 43 | ADRBK1 | 0.82809181 |
| 44 | KIT | 0.81515777 |
| 45 | PRKCQ | 0.80154906 |
| 46 | CLK1 | 0.79712156 |
| 47 | CSNK1G1 | 0.77977325 |
| 48 | PLK3 | 0.77617455 |
| 49 | MAP3K4 | 0.76878280 |
| 50 | PRKCE | 0.75436689 |
| 51 | CSF1R | 0.72169843 |
| 52 | GRK7 | 0.70953717 |
| 53 | DAPK1 | 0.69824110 |
| 54 | TNK2 | 0.68421653 |
| 55 | STK11 | 0.66930060 |
| 56 | PIK3CA | 0.65783492 |
| 57 | PRKCG | 0.62396434 |
| 58 | HIPK2 | 0.59175047 |
| 59 | LYN | 0.58721664 |
| 60 | DAPK2 | 0.57287370 |
| 61 | STK39 | 0.56314432 |
| 62 | SYK | 0.55499962 |
| 63 | ERBB3 | 0.55082504 |
| 64 | PIK3CG | 0.55073482 |
| 65 | HCK | 0.54695872 |
| 66 | MAP3K11 | 0.53909736 |
| 67 | CHUK | 0.52730708 |
| 68 | STK3 | 0.49090466 |
| 69 | DYRK1A | 0.47193509 |
| 70 | CSNK1G2 | 0.46684250 |
| 71 | MKNK2 | 0.45962995 |
| 72 | CSNK1G3 | 0.44074606 |
| 73 | FGFR2 | 0.43848470 |
| 74 | TRPM7 | 0.43831032 |
| 75 | STK4 | 0.42459813 |
| 76 | GSK3A | 0.41900570 |
| 77 | WEE1 | 0.41867200 |
| 78 | MARK3 | 0.41507628 |
| 79 | MAP3K14 | 0.41441352 |
| 80 | MAPK11 | 0.40741050 |
| 81 | BCKDK | 0.40660222 |
| 82 | RPS6KA5 | 0.40294454 |
| 83 | MAPKAPK5 | 0.39681576 |
| 84 | PRKAA2 | 0.39424834 |
| 85 | PLK2 | 0.39304283 |
| 86 | MUSK | 0.39161650 |
| 87 | MELK | 0.38633915 |
| 88 | IGF1R | 0.38351447 |
| 89 | ABL1 | 0.38083035 |
| 90 | CSNK1A1L | 0.37980334 |
| 91 | PAK3 | 0.37079260 |
| 92 | CAMK2A | 0.36786213 |
| 93 | STK38L | 0.36630463 |
| 94 | TGFBR1 | 0.36585255 |
| 95 | LCK | 0.36531482 |
| 96 | PTK2B | 0.35700144 |
| 97 | CAMK1 | 0.35137514 |
| 98 | TBK1 | 0.33420912 |
| 99 | TRIM28 | 0.33075571 |
| 100 | CSNK1A1 | 0.31905285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.86472302 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 2.78375039 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.51008919 |
| 4 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.48732892 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.43826735 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.40217448 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.40203835 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.38092964 |
| 9 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.37371403 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.29343167 |
| 11 | Phototransduction_Homo sapiens_hsa04744 | 2.20218637 |
| 12 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.19756001 |
| 13 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.19128736 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.12958173 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.01509836 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.84411305 |
| 17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.83995420 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.81776563 |
| 19 | Protein export_Homo sapiens_hsa03060 | 1.74195902 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72559243 |
| 21 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.71131157 |
| 22 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.62183648 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.60155409 |
| 24 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.58664547 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.57719219 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.53412174 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52094953 |
| 28 | Basal transcription factors_Homo sapiens_hsa03022 | 1.49157179 |
| 29 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.48840963 |
| 30 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.45993508 |
| 31 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45887243 |
| 32 | RNA degradation_Homo sapiens_hsa03018 | 1.45532031 |
| 33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37548073 |
| 34 | Nicotine addiction_Homo sapiens_hsa05033 | 1.36192014 |
| 35 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.33582388 |
| 36 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.31317090 |
| 37 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.26544608 |
| 38 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19358544 |
| 39 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.17529237 |
| 40 | Olfactory transduction_Homo sapiens_hsa04740 | 1.14624079 |
| 41 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.08580454 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.08566974 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05903639 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.05061386 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03472270 |
| 46 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.93570890 |
| 47 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90389739 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.89438429 |
| 49 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.89425281 |
| 50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.88835024 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.87630387 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85169708 |
| 53 | Morphine addiction_Homo sapiens_hsa05032 | 0.83381305 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.83163117 |
| 55 | Alzheimers disease_Homo sapiens_hsa05010 | 0.81100093 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78726349 |
| 57 | RNA polymerase_Homo sapiens_hsa03020 | 0.77774571 |
| 58 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74563721 |
| 59 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.72042627 |
| 60 | Peroxisome_Homo sapiens_hsa04146 | 0.69412245 |
| 61 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65864053 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65108801 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.64706971 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64408615 |
| 65 | Taste transduction_Homo sapiens_hsa04742 | 0.63698190 |
| 66 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61034868 |
| 67 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.60976572 |
| 68 | Mismatch repair_Homo sapiens_hsa03430 | 0.60545549 |
| 69 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.60271991 |
| 70 | Huntingtons disease_Homo sapiens_hsa05016 | 0.57650524 |
| 71 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.56954824 |
| 72 | Salivary secretion_Homo sapiens_hsa04970 | 0.56417768 |
| 73 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55777867 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55523452 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.53719453 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.53230027 |
| 77 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.52229218 |
| 78 | Insulin secretion_Homo sapiens_hsa04911 | 0.50682655 |
| 79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50170500 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.49577236 |
| 81 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.48133949 |
| 82 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.47442342 |
| 83 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.45253242 |
| 84 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45010805 |
| 85 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44737750 |
| 86 | Mineral absorption_Homo sapiens_hsa04978 | 0.41241514 |
| 87 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.41096708 |
| 88 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.39697517 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38744161 |
| 90 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.38374310 |
| 91 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.37074197 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33789084 |
| 93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.33336656 |
| 94 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.30102623 |
| 95 | GABAergic synapse_Homo sapiens_hsa04727 | 0.29551840 |
| 96 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.29125231 |
| 97 | Circadian entrainment_Homo sapiens_hsa04713 | 0.28701179 |
| 98 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28494318 |
| 99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.27940669 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.27443599 |

